Yükleniyor... / Loading...
This study examined the function of the inner lining of blood vessels (endothelium) using EndoPAT measurement and blood tests in patients with pulmonary arterial hypertension. It enrolled patients over 18 whose diagnosis was confirmed by right heart catheterization. It was conducted as a trial with no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * proven PH (by right heart catheterization, PAP \>25 mmHg, within last 12 months) * age \>18 years * Dana Point classification I or IV (all subgroups) * declaration of consent Exclusion Criteria: * Pulmonary Hypertension not proven by right heart catheterization * Eisenmenger's syndrome/reaction * PH other than Dana Point I and IV * alcohol or drug abuse * non-compliance due to any cause (e.g. severe psychiatric disorder)